
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.160 | 2.160 | 0.000 |
Shares | 97.840 | 97.840 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.671 | 17.901 |
Price to Book | 5.241 | 2.969 |
Price to Sales | 4.567 | 2.199 |
Price to Cash Flow | 18.899 | 11.852 |
Dividend Yield | 1.462 | 2.077 |
5 Years Earnings Growth | 9.292 | 10.075 |
Name | Net % | Category Average |
---|---|---|
Technology | 29.260 | 23.529 |
Financial Services | 24.210 | 16.945 |
Healthcare | 17.170 | 12.932 |
Consumer Defensive | 12.360 | 7.530 |
Industrials | 8.120 | 11.820 |
Consumer Cyclical | 6.590 | 10.485 |
Communication Services | 2.300 | 7.932 |
Number of long holdings: 42
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.14 | 473.22 | +0.60% | |
SAP | DE0007164600 | 6.78 | 267.600 | -1.74% | |
Visa A | US92826C8394 | 6.54 | 367.21 | -0.81% | |
Aon | IE00BLP1HW54 | 4.35 | 355.77 | -4.13% | |
L'Oreal | FR0000120321 | 4.21 | 378.90 | -0.64% | |
Accenture | IE00B4BNMY34 | 3.73 | 317.87 | +0.07% | |
Relx | GB00B2B0DG97 | 3.39 | 3,921.00 | -1.36% | |
Coca-Cola | US1912161007 | 3.31 | 71.64 | +0.40% | |
Arthur J Gallagher | US3635761097 | 3.30 | 319.06 | -2.95% | |
P&G | US7427181091 | 3.28 | 162.35 | -1.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.41B | 3.14 | 5.49 | 9.13 | ||
Adamant Medtech I USD | 1.41B | 3.44 | 6.23 | 9.90 | ||
EDM Intl S American Growth A USD | 329.43M | -8.51 | 0.92 | 10.60 | ||
LU1811047247 | 227.95M | -1.98 | 1.74 | - | ||
LU1811047593 | 227.95M | -2.21 | 1.03 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review